Valiant Organics Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹159Cr
- −15% YoY
- +1.3% QoQ
- Net profit
- ₹4Cr
- −20% YoY
- −33.3% QoQ
- Margin
- 8%
- 0 pp YoY
- −5 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Valiant Organics Ltd's Q3 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q3-FY26 Consolidated Revenue from Operations: INR 1,593 Mn, down 14.8% YoY (Q3-FY25: INR 1,869 Mn) - Q3-FY26 Standalone Revenue from Operations: INR 1,591 Mn, down 14.9% YoY (Q3-FY25: INR 1,869 Mn) - Key chemistry sales volumes (Metric Tons, MT) for Q3-FY26 vs Q3-FY25: - Chlorination: decreased from 380 MT to 362 MT - Hydrogenation: decreased from 286 MT to 258 MT - Ammonolysis: steady around 93 MT (Q3-FY25: 97 MT) - Others: slight decrease from 97 MT to 93 MT - Revenue breakup Q3-FY26 by chemistry: Chlorination 23%, Hydrogenation 43%, Ammonolysis 28%, Others 6% - Q3-FY26 Consolidated Financials: - EBITDA: INR 156 Mn, up 1.3% YoY from INR 154 Mn.
From Valiant Organics Ltd's Q3 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q3-FY26 Consolidated Revenue from Operations: INR 1,593 Mn, down 14.8% YoY (Q3-FY25: INR 1,869 Mn)
- Q3-FY26 Standalone Revenue from Operations: INR 1,591 Mn, down 14.9% YoY (Q3-FY25: INR 1,869 Mn)
- Key chemistry sales volumes (Metric Tons, MT) for Q3-FY26 vs Q3-FY25:
- Chlorination: decreased from 380 MT to 362 MT
- Hydrogenation: decreased from 286 MT to 258 MT
- Ammonolysis: steady around 93 MT (Q3-FY25: 97 MT)
- Others: slight decrease from 97 MT to 93 MT
2 more points from Valiant Organics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what Valiant Organics Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.
Valiant Organics Ltd — Quarterly revenue & net profit
Valiant Organics Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 159 | 187 | -15% | 157 | +1.3% |
| Operating profit (EBITDA) | 13 | 15 | -13.3% | 21 | -38.1% |
| Operating margin | 8% | 8% | 0 pp | 13% | -5 pp |
| Profit before tax | 6 | 6 | 0% | 7 | -14.3% |
| Net profit (PAT) | 4 | 5 | -20% | 6 | -33.3% |
| EPS (₹) | 1.30 | 1.98 | -34.3% | 2.02 | -35.6% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Neochem Bio (Q3 FY26)
Revenue for Q2 FY26 (Sept’25) stood at ₹4,583.16 Lakh. Key investor presentation takeaways from Neochem Bio Solutions Ltd's Q3 FY26 investor presentation — and
- Thirumalai Chemicals (Q3 FY26)
Q3 FY26 Revenue from Operations (INR Cr):** . Key investor presentation takeaways from Thirumalai Chemicals Ltd's Q3 FY26 investor presentation — and how it ran
- IVP (Q3 FY26)
Q3 FY26 Revenue from Operations: ₹144.97 crore . Key investor presentation takeaways from IVP's Q3 FY26 investor presentation — and how it ranks against sector
- Gujarat Alkalies (Q3 FY26)
3,144.48 Crores, down from Rs. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY26 investor presentation — and how it ranks agai
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Valiant Organics Ltd Q3 FY26 results?
Q3-FY26 Consolidated Revenue from Operations: INR 1,593 Mn, down 14.8% YoY (Q3-FY25: INR 1,869 Mn) - Q3-FY26 Standalone Revenue from Operations: INR 1,591 Mn, down 14.9% YoY (Q3-FY25: INR 1,869 Mn) - Key chemistry sales volumes (Metric Tons, MT) for Q3-FY26 vs Q3-FY25: - Chlorination: decreased from 380 MT to 362 MT - Hydrogenation: decreased from 286 MT to 258 MT - Ammonolysis: steady around 93 MT (Q3-FY25: 97 MT) - Others: slight decrease from 97 MT to 93 MT - Revenue breakup Q3-FY26 by chemistry: Chlorination 23%, Hydrogenation 43%, Ammonolysis 28%, Others 6% - Q3-FY26 Consolidated Financials: - EBITDA: INR 156 Mn, up 1.3% YoY from INR 154 Mn.
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
